Investing Profile

Vineeta Agarwala

VCInvestor
General Partner at Andreessen Horowitz
a16z.com/author/vineeta-agarw...San Francisco Bay Area
Photo of Vineeta Agarwala, General Partner at Andreessen Horowitz
Your Intro Paths to Vineeta Agarwala

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Vineeta is a member of
Stanford University Network
1408 CONNECTIONS
Harvard University Network
897 CONNECTIONS
Mckinsey & Company Network
765 CONNECTIONS
Andreessen Horowitz Network
268 CONNECTIONS
Harvard Medical School Network
76 CONNECTIONS

Find Vineeta Agarwala on

cb
Current Investing Position
Andreessen Horowitz General Partner
Investment Range
$10K - $100.0M
Sweet Spot
$10.0M
Investments On Record
33
Current Fund Size
$2.2B

Vineeta Agarwala is on these Sector & Stage Rankings

Vineeta Agarwala's Investments On Record (19)

CompanyStageDateRound SizeTotal Raised
Thyme Care
Series ESep 2026$130M
Series DSep 2025$97M
Series CJul 2024$55M
Series BAug 2023$60M
Series AOct 2021$22M
$360M
Co-investors: Brenton Fargnoli (AlleyCorp), Vijay Patel (CVS Health Ventures), Faraz Rahman (CVS Health Ventures), David Whelan (Town Hall Ventures), Kurt Sheline (Echo Health Ventures), Vivek Garipalli (Wormhole Capital)
Pearl Health
Series CJul 2026$50M
Series BJan 2023$55M
Series ASep 2021$18M
$120M
Co-investors: Scott Kupor (Andreessen Horowitz), Kevin Ryan (AlleyCorp)
Stipple Bio
Series AApr 2026$100M
$100M
Co-investors: Derek DiRocco (RA Capital Management), Thilo Schroeder (Nextech Invest)
Pomelo Care
Series CJan 2026$92M
Series BJun 2024$46M
Series AJun 2023$33M
$170M
Co-investors: Josh Kopelman (First Round Capital), Aaron Shapiro (Stripes Group)
Gate Bioscience
Series BNov 2025$65M
Series ANov 2023$60M
$130M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Scott Biller (GV (Google Ventures)), Jay Parrish (ARCH Venture Partners), Clare Ozawa (Versant Ventures)
knownwell
Series BOct 2025$25M
Series ADec 2023$20M
$50M
Co-investors: Ian Chiang (Flare Capital Partners), Varsha Rao (ViaSat Inc.), Larry Summers
Arda Therapeutics
Series AOct 2024$43M
$43M
Co-investors: Rebecca (Becky) Pferdehirt (Andreessen Horowitz), Matthew Caspari (Alumni Ventures ), Konstantin von Unger (Hotmail)
GC Therapeutics
Series ASep 2024$65M
$65M
Co-investors: Alaa Halawa (Mubadala)

most interested in

therapeutics, diagnostics, and digital health, with a focus on companies that are leveraging unique datasets to improve drug development and patient care delivery

Vineeta Agarwala's Experience

Research Scientist Lawrence Livermore National LaboratoryPresent
Business Analyst Mckinsey & CompanyPresent
MD/PhD Broad Institute of MIT and HarvardPresent
Data Scientist Kyruus HealthPresent
Data Scientist KyruusPresent
Product Manager Flatiron HealthPresent
Director, Product Management Flatiron HealthPresent
Adjunct Clinical Assistant Professor Stanford University School of MedicinePresent
Adjunct Clinical Assistant Professor Stanford University School of Medicine InternshipPresent
Adjunct Clinical Assistant Professor Stanford Center for Clinical Research (SCCR)Present
Board Member National Venture Capital AssociationPresent
Committee Member Harvard Medical SchoolPresent
Board Director Tenet HealthcarePresent
Venture Partner GV (Google Ventures)Present
Venture Partner GVPresent
General Partner Andreessen HorowitzPresent

Vineeta Agarwala's Education

Stanford Hospital & Clinics Internal Medicine Board Certified
Harvard University Ph.D. Biophysics
Harvard Medical School Doctor of Medicine (M.D.) Harvard-MIT HST Program
Stanford University B.S. Biophysics

Investors who invest with Vineeta Agarwala

Sign in with Google →

Scouts & Angels Affiliated With Vineeta Agarwala

Sign in with Google →